1. |
Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood, 2016, 127(22): 2672-2681.
|
2. |
Girschikofsky M, Arico M, Castillo D, et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis, 2013, 8: 72.
|
3. |
Suri HS, Yi ES, Nowakowski GS, et al. Pulmonary langerhans cell histiocytosis. Orphanet J Rare Dis, 2012, 7: 16.
|
4. |
Ma J, Laird JH, Chau KW, et al. Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies. Cancer Med, 2019, 8(1): 58-66.
|
5. |
Gupta N, Langenderfer D, McCormack FX, et al. Chest computed tomographic image screening for cystic lung diseases in patients with spontaneous pneumothorax is cost effective. Ann Am Thorac Soc, 2017, 14(1): 17-25.
|
6. |
Radzikowska E, Błasińska-Przerwa K, Wiatr E, et al. Pneumothorax in patients with pulmonary Langerhans cell histiocytosis. Lung, 2018, 196(6): 715-720.
|
7. |
Le Guen P, Chevret S, Bugnet E, et al. Management and outcomes of pneumothorax in adult patients with Langerhans cell Histiocytosis. Orphanet J Rare Dis, 2019, 14(1): 229.
|
8. |
Agarwal KK, Seth R, Behra A, et al. 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations. Jpn J Radiol, 2016, 34(4): 267-276.
|
9. |
Haroche J, Cohen-Aubart F, Rollins BJ, et al. Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol, 2017, 18(2): e113-e125.
|
10. |
Roden AC, Hu XW, Kip S, et al. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol, 2014, 38(4): 548-551.
|
11. |
Mourah S, How-Kit A, Meignin V, et al. Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis. Eur Respir J, 2016, 47(6): 1785-1796.
|
12. |
Phulware RH, Guleria P, Iyer VK, et al. Cytological diagnosis of Langerhans cell histiocytosis: a series of 47 cases. Cytopathology, 2019, 30(4): 413-418.
|
13. |
Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med, 2002, 346(7): 484-490.
|
14. |
Badalian-Very G, Vergilio JA, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood, 2010, 116(11): 1919-1923.
|
15. |
Kolenová A, Schwentner R, Jug G, et al. Targeted inhibition of the MAPK pathway: emerging salvage option for progressive life-threatening multisystem LCH. Blood Adv, 2017, 1(6): 352-356.
|
16. |
周婧, 李霞, 张稷, 等. 双肺移植后复发性朗格汉斯细胞组织细胞增生症1例并文献复习. 实用器官移植电子杂志, 2019, 7(5): 371-374.
|